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Nr-CAM knockouts as observed previously in islet-2
knockouts. This suggests that either there is a guidance
mechanism specific for contralateral VT axons or that,
outside the VT, Nr-CAM acts redundantly with other
CAMs or partners. Although Williams et al. showed
that several Ig-CAMs known to interact with Nr-CAM
are expressed by RGCs, none appears specific for con-
tralateral neurons outside the VT. Another important
question will be to determine whether Nr-CAM expres-
sion is regulated by zic-2 and islet-2 transcription fac-
tors, both of which appear to control EphB1 expression.
One may expect Nr-CAM expression in RGCs to be
downregulated in islet-2 knockout and upregulated in
zic-2 knockouts. However, the absence of significant
cross-talk between the EphB1/ephrin-B2 and Nr-CAM
pathways could also signify that their genetic determi-
nation differs. In conclusion, this work by Williams
et al., together with recent studies on VT projections
(Herrera et al., 2003; Williams et al., 2003; Pak et al.,
2004), is setting new standards for the analysis of
crossed and uncrossed visual projections in existing
and forthcoming mouse mutants. This also confirms
that, as originally thought, Ig-CAMs, either as receptors
for slits and netrins or semaphorins or for other un-
known ligands, hold the keys to axon guidance across
the midline.
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521GABAB Receptor Isoforms
Caught in Action at the Scene
The metabotropic GABAB receptors mediate slow syn-
aptic inhibition and consist of heterodimers of
GABAB1 and GABAB2 subunits. The only known molec-
ular diversity of the GABAB receptors arises from the
two GABAB1 isoforms, but its functional significance
has been unclear. Two studies in this issue of Neuron
now demonstrate that GABAB1a and GABAB1b show
strategically distinct subcellular localization and phys-
iological action.
Although GABA is the only major inhibitory neurotrans-
mitter in the vertebrate brain, there are many different
modes of inhibition, which act in concert to control syn-
aptic integration, spike generation, and nearly all as-
pects of circuit activity. The GABAergic system seems
to have deployed at least two strategies to greatly enrich
the action of GABA. First, a different ‘‘flavor’’ of GABA is
released by a rich array of interneuron subtypes at dis-
tinct spatial and temporal niches in the neural circuit
(e.g., at different subcellular locations and precisely de-
fined time windows during circuit operation). Second,
different physiological effects of GABA are transmitted
by a large variety of GABA receptors. For example, the
fast component of GABAergic inhibition is mediated by
the ionotropic GABAA receptors. The GABAA receptor
family includes at least 17 genes. Each functional recep-
tor consists of a pentamer of different subunits, which
allows combinatorial coding of different biophysical and
pharmacological properties. In addition, GABA also
activates slow synaptic inhibition through the metabo-
tropic GABAB receptors, which are coupled to hetertri-
meric G proteins. Activation of presynaptic GABAB
receptors located on GABAergic terminals (autorecep-
tors) or other nerve terminals (heteroreceptors) sup-
presses neurotransmitter release, whereas the stimula-
tion of postsynaptic receptors produces a prolonged
neuronal hyperpolarization. Although biochemical and
pharmacological studies have long suggested the pres-
ence of diverse GABAB receptor subtypes (Kerr and Ong,
1995), molecular cloning has only identified two genes
encoding receptor subunits: GABAB1 and GABAB2 (Bet-
tler et al., 2004). It is now fairly well established that most
functional GABAB receptors in the brain are formed as
GABAB1 and GABAB2 heterodimers (Mohler and Frit-
schy, 1999). Therefore, the presumed diversity of native
GABAB receptor subtypes in various in vivo preparations
stands in contrast to the apparent simplicity of their ba-
sic molecular architecture. Two studies led by Bettler
(Vigot et al., 2006) and Larkum (Pe´rez-Garci et al., 2006)
in this issue ofNeuron provide insight to this conundrum
and bring our understanding of the GABAB receptor sys-
tem to a deeper level.
The only firmly established molecular diversity in the
GABAB system thus far arises from the two isoforms of
the GABAB1 subunit: GABAB1a and GABAB1b (Kaupmann
et al., 1998). However, these two isoforms seem to have
very similar pharmacological and biophysical properties
in vitro (Brauner-Osborne and Krogsgaard-Larsen,
Neuron
5221999). Structurally, the only difference between the two
isoforms is the presence of a pair of sushi repeats in the
N-terminal ectodomain of GABAB1a (Bettler et al., 2004).
Since sushi repeats have been shown to mediate protein
interactions with a variety of cell adhesion molecules
(Blein et al., 2004), their presence in GABAB1a suggests
the possibility that the two isoforms may associate
with distinct auxiliary proteins for their localization and
modification (Couve et al., 2004; Mohler and Fritschy,
1999). However, most, if not all neurons co-express both
GABAB1a and GABAB1b, and there has been no solid
evidence for differential subcellular localization (e.g.,
pre- versus postsynaptic) of these isoforms. It is there-
fore not obvious whether and how GABAB1a and
GABAB1b support the distinct physiological properties
and functions in vivo. Clear answers to these important
questions require a high-resolution examination of the
cellular and subcellular localization and physiological
action of GABAB1a (1a) and GABAB1b (1b) at specific
connections in defined neural circuits, combined with
specific inactivation of each isoform in vivo. Vigot et al.
and Pe´rez-Garci et al. did exactly these experiments.
GABAB1a and GABAB1b are generated by differential
promoter usage of the GABAB1 gene; GABAB1b results
from the presence of an alternative transcription initia-
tion site within the fifth GABAB1a intron. Vigot et al.
took advantage of this unusual genomic structure and
converted the initiation codon of each isoform into
a stop codon using a knockin approach. This elegant ge-
netic manipulation inactivates one isoform at a time
while leaving the other intact (the 1a2/2 or 1b2/2
mice). These mutant mice provide a unique opportunity
to dissect the function of GABAB1a and GABAB1b iso-
forms. Vigot et al. focused their analysis at the CA3 to
CA1 connections of the adult hippocampus.
The lack of a suitable GABAB1a or GABAB1b specific
antibody for ultrastructural studies has precluded the
precise analysis of their subcellular localization. Using
their isoform-specific mutants and a pan-GABAB1 anti-
body, Vigot et al. was able to quantify the subcellular
distribution of each remaining isoform in either 1a2/2
or 1b2/2 mice by electron microscopy. They found
that GABAB1b was mostly localized to dendritic spines
opposite to glutamate release sites, while GABAB1a is
predominantly found at glutamatergic terminals. Analy-
sis of CA3-CA1 transmission indicated that 1a2/2 but
not 1b2/2 mice lacked GABAB heteroreceptors on
Schaffer collateral terminals; on the other hand, post-
synaptic CA1 pyramidal neurons in 1b2/2 but not
1a2/2 mice showed greatly reduced slow inhibitory
current induced by the GABAB agonist baclofen. To fur-
ther examine the issue of subcellular localization, GFP-
tagged GABAB1a or GABAB1b were expressed in CA1 py-
ramidal neurons of hippocampal organotypic cultures.
Although both tagged isoforms were present in den-
drites, GABAB1b–GFP was largely localized to spines
while GABAB1a–GFP was largely excluded from this
site. In addition, only GABAB1a-GFP was targeted to
axons. Together these results strongly suggest that
GABAB1a mainly assembles presynaptic heterorecep-
tors inhibiting glutamate release, while GABAB1b recep-
tors mainly mediate postsynaptic inhibition. In addition,
the sushi repeats in GABAB1a may contribute to hetero-
receptor localization.To explore whether GABAB1a and GABAB1b play dis-
tinct roles in synaptic plasticity, long-term potentiation
at CA3-CA1 synapses was measured in 1a2/2 and
1b2/2 mice. Although 1b2/2 mice exhibited normal
LTP, 1a2/2 mice showed significantly impaired LTP.
To examine the behavioral consequence of such LTP
deficit, 1a2/2 and 1b2/2mice were subjected to a hip-
pocampal-dependent object recognition task. While
1b2/2 mice showed similar performance as wild-type
mice in discriminating between familiar or novel objects,
1a2/2 mice were impaired in this task. Together, these
studies provide compelling evidence that GABAB1a and
GABAB1b indeed have distinct functions in synaptic
physiology and behavior, and deficiency in one isoform
cannot be compensated for by the other. On the other
hand, since LTP can be induced even after acute phar-
macological blockade of GABAB receptors, the LTP def-
icits in 1a2/2 mice most likely result from adaptive
changes following germ-line inactivation of this isoform.
Consistent with this interpretation, The proportion of
silent synapses was decreased in the hippocampus of
1a2/2mice. This finding therefore revealed an interest-
ing compensatory mechanism by which developmental
GABAB receptor deficit results in behavioral abnormality
through altering a plasticity process.
While Vigot et al. provided strong evidence for differ-
ent functions of GABAB1 isoforms in hippocampus,
the study by Pe´rez-Garci et al. in the accompanying
paper nailed this issue at the cellular level with a particu-
larly clean case, by demonstrating that GABAB1a and GA-
BAB1b play strategically distinct physiological roles in
neocortical neurons (Figure 1). The success of this study
can be attributed both to the choice of studying synaptic
inputs onto layer 5 (L5) pyramidal neurons in neocortex,
where 1a and 1b turn out to have cleanly divided their
physiological tasks, and to the elegant physiological par-
adigm that allowed interrogation of these neurons with
whole-cell patch recording at multiple subcellular sites.
L5 pyramidal neurons extend their axons and den-
drites to all cortical layers and are characterized by their
striking polarity and intrinsic compartmental architec-
ture both at the anatomical and physiological levels.
They receive convergent excitatory inputs from layer 1
(L1) fibers which carry top-down information from higher
cortical areas, and information from thalamocortical
pathways and other cortical areas. They are unusual in
having both an axonal and a dendritic zone for the initi-
ation of action potentials (Larkum et al., 2001, Figure 1).
Distal dendritic inputs must evoke a calcium action po-
tential (Ca2+-AP) at the dendritic initiation zone, which
can propagate forwardly and generate a burst of axonal
action potentials. On the other hand, back-propagating
action potentials from the axon facilitates the initiation of
these Ca2+-APs when it coincides with the distal inputs
within a time window of several milliseconds (Larkum
et al., 1999). Such a temporal requirement of distal in-
puts with ongoing somatic spiking to facilitate dendritic
Ca2+-APs has been suggested as a mechanism by which
cortical neurons associate inputs arriving at different
cortical layers. In addition, the apical tuft of L5 pyramidal
neurons is innervated by a large number of inhibitory in-
puts with as yet unclear function (Figure 1). The interac-
tion of excitatory and inhibitory actions on the distal api-
cal dendrite is likely a rich source of computation
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523Figure 1. GABAB1a and GABAB1b Show Dis-
tinct Subcellular Localization and Physiologi-
cal Actions
Layer 1 stimulated glutamatergic (green) and
GABAergic (pink) inputs onto layer 5 pyrami-
dal neurons (blue; Perez-Carci et al., 2006)
are represented in a schematic on the left
and described in the text. Synaptic connec-
tions in the gray circle are diagramed on the
right. Ca-APs: dendritic calcium action po-
tentials; Na-APs: axon initiated sodium action
potentials. Darker blue color in the apical
dendrite represents the preferential distal
dendritic localization of GABAB1b in layer 5
pyramidal neurons. Small circles: synaptic
vesicles; small diamonds: sushi repeats. At
the CA3-CA1 connection in hippocampus,
GABAB1a also constitute heteroreceptors on
the glutamatergic terminal (Vigot et al., 2006).possibilities. For example, Ca2+ spikes in L5 pyramidal
neurons are exceedingly susceptible to local inhibitory
inputs. A single action potential from an interneuron in
L2/3 can abolish dendritic Ca2+ spikes without affecting
the generation or back-propagation of axonally initiated
sodium action potentials (Na+-APs) (Larkum et al., 1999),
thereby would decouple inputs which would otherwise
associate in L5 pyramidal neurons. Surprisingly, the ef-
fect of inhibition can last for over 400 ms (Larkum et al.,
1999). The cellular and molecular mechanism underlying
this powerful and long-lasting inhibition is unknown.
In the current study, Pe´rez-Garci et al. demonstrate
the role of GABAB receptors, specifically the GABAB1b
isoform, in mediating the long-lasting inhibition of den-
dritic Ca spikes in L5 pyramidal neurons.
Their experiments mainly involved using multiple
patch electrodes to trigger and measure electrical sig-
nals from the apical tuft, dendrite, and soma of L5
pyramidal neurons, combined with calcium imaging at
subcellular locations. Inhibition was generated from
extracellular stimulation in L1. GABAB receptors were
manipulated either by local puffing of agonists/antago-
nists onto defined subcellular regions or by the use of
GABAB1 isoform-specific mutant mice. To substantiate
previous findings, Pe´rez-Garci et al. first measured the
entire time window of L1 triggered inhibition in blocking
dendritic Ca2+ spikes and showed that it lasted for up to
450 ms. Importantly, such inhibition recruited by L1
stimulation is restricted to the distal dendrites and did
not shunt the back-propagating Na+-APs, suggesting
that either a dendritically targeted GABAergic input or
a dendritic distribution of specific GABA receptors
may mediate this form of slow inhibition in L5 pyramidal
neurons. Using pharmacological methods, they further
demonstrated that the inhibition consists of two compo-
nents: GABAA receptors mediate the short (<150 ms)
component while GABAB receptors mediate the long
(>150 ms) component. GABAB receptors are known to
activate postsynaptic K+ currents and also inhibit Ca2+
currents. By pharmacologically isolating the Ca2+ and
K+ currents, Pe´rez-Garci et al. was able to show that GA-
BAB activation directly inhibited Ca
2+ conductances that
participate in dendritic spiking.To examine whether a specific isoform of GABAB re-
ceptor is responsible for the inhibition of dendritic
Ca2+ spike, Pe´rez-Garci et al. took full advantage of the
1a2/2 and 1b2/2mice generated by Vigot et al. The re-
sult was particularly satisfying: L5 pyramidal neurons
from 1a2/2 mice were the same as those from wt
mice, which displayed both short and long lasting com-
ponents of inhibition. In contrast, L5 pyramidal neurons
from 1b2/2mice completely lacked the long-lasting in-
hibitory component, while the short, GABAA-mediated
component was intact. In addition, local puffing of
baclofen only to the dendrites but not the soma elicited
GABAB response. Therefore, GABAB1b is not only spe-
cifically involved in mediating the L1-triggered long last-
ing inhibition in L5 pyramidal neurons, but also is prefer-
entially targeted to distal dendrites (Figure 1).
An interesting surprise came when Pe´rez-Garci et al.
took a closer look at the biphasic IPSPs evoked by L1
stimulation: GABAB antagonist in fact significantly in-
creased the amplitude of the fast IPSP component.
This is best explained by the disinhibition of GABAergic
terminals by the blockage of presynaptic GABAB auto-
receptors, resulting in more GABA release. Consistent
with this notion, presynaptic inhibition was absent in
1a2/2 but not 1b2/2 mice, suggesting that GABAB1a
exclusively makes up the presynaptic autoreceptors
in the inhibitory terminals in this circuit (Figure 1).
Therefore, when examined at exactly the right place
and the right time, strategically distinct physiological
roles of GABAB receptors can be revealed as a clean
segregation of 1a and 1b isoforms at the cellular and
subcellular levels. Is L5 pyramidal neuron the exception
or the rule? Only more elegant studies like those of
Pe´rez-Garci will tell.
Together, these two studies provide compelling evi-
dence for the cell biological, physiological, and func-
tional distinctions of GABAB1 isoforms. They also raised
many more questions. First, what is the mechanism that
targets 1a and 1b to different subcellular locations?
Since the only structural difference between GABAB1a
and GABAB1b lies in the sushi repeats, extracellular in-
teractions with putative auxiliary proteins may deter-
mine their subcellular localization (e.g., by selective
Seeing What the Mouse Sees
with Its Vibrissae: A Matter
of Behavioral State
The behavioral state of an animal is accompanied by
ongoing brain activity that primes neuronal circuitry
to sensory inputs. While it should come as no surprise
that the pattern of cortical activation is tied to be-
havioral states, only now has this dependence been
imaged. In this issue of Neuron, Ferezou, Bolea, and
Petersen show that the level and spatial extent of acti-
vation of vibrissa sensory cortex critically depend on
behavioral context and mode of stimulation, i.e., pas-
sive versus active contact.
The central focus of systems neuroscience is to relate
behavior to the underlying neuronal circuitry. Yet, for
reasons of experimental convenience and control, the
issue of behavior is often dropped, as the vast majority
of neurophysiological studies on sensory encoding are
performed on anesthetized (nonbehaving) animals. While
this approach quenches neuronal feedback and thus
exposes patterns of afferent inputs, the use of anesthe-
tized preparations introduces biases in understanding
the nature of sensory systems. Consider obvious differ-
ences between sensory processing in awake and anes-
thetized animals. First, brain dynamics during wakeful-
ness are modified by an array of neuromodulators that
are selectively released according to behavioral state
(McCormick and Bal, 1997). Second, active positioning
of sensors, such as tracking in vision or touch, or
active changes in the sensory stream, such as sniffing
in olfaction or tapping in touch, directly influence how
stimuli are encountered and thus encoded by the
nervous system. Third, attentional mechanisms, which
depend on prior experiences and the expectation of
reward, dynamically alter the manner in which neuronal
circuits respond to stimuli.
Why is the use of awake behaving preparations still
the exception rather than the rule for the study of cortical
dynamics? To be fair, much primate research involves
the use of awake animals. This reflects the relative
ease with which primates can be trained both to do
tasks and to sit comfortably with their head fixed so
that electrodes may be inserted and removed. But the
focus on awake animals has, for the most part, not fil-
tered down to the rodent sensory community, despite
the beautiful pioneering work of Chapin and Woodward
(1982) on motor control of somatosensory input in free-
ranging rats. Part of the problem is technical. However,
Neuron
524transport or retention). In fact, the two sushi repeats in
1a have strikingly different structural properties and par-
ticipate in protein interactions with multiple partners
(Blein et al., 2004), which may generate additional het-
erogeneity in the GABAB receptor system. It is possible
that the extracellular domain of GABAB1 isoforms may
interact with proteins not only on the same cell but
also those on the synaptic partners or in the extracellular
matrix to achieve proper subcellular localization. Sec-
ond, are different isoforms of GABAB receptors at differ-
ent subcellular locations (e.g., dendritic shaft versus
spine of CA1 pyramidal neurons) also preferentially ex-
posed to distinct subtypes of GABA terminals? There
is evidence that only certain subtypes of interneurons
activate GABAB receptors. Neurogliaform cells in the
neocortex are such an example and appear to preferen-
tially innervate GABAB receptor-containing dendritic
spines (Tamas et al., 2003). Is it possible that GABAB1
isoforms might contribute to a matching of pre- and
postsynaptic sites through organizing extracellular pro-
tein interactions? Third, the learning and memory defi-
cits in 1a2/2 mice may have resulted from altered de-
velopmental plasticity processes due to constitutive
germ-line knockout. To further pin-point the precise
physiological and behavioral functions of GABAB1 iso-
forms, conditional inactivation of 1a and 1b in specific
neural circuits in the mature brain is necessary. Finally,
although the molecular identities and functions of two
distinct GABAB subtypes are finally recognized by these
studies, it is still difficult to explain the apparently more
diverse GABAB physiological responses in vivo (Kerr
and Ong, 1995). It is possible that further functional var-
iations of GABAB receptors may arise from the modifica-
tion of these two ‘‘prototype’’ GABAB1 isoforms, for ex-
ample, by auxiliary proteins and post-translational
mechanisms. Identification of GABAB receptor-interact-
ing proteins and characterization of their expression will
undoubtedly provide further insight into the finer organi-
zation of the GABAB system.
Z. Josh Huang1
1Cold Spring Harbor Laboratory
Cold Spring Harbor, New York 11724
Selected Reading
Bettler, B., Kaupmann, K., Mosbacher, J., and Gassmann, M. (2004).
Physiol. Rev. 84, 835–867.
Blein, S., Ginham, R., Uhrin, D., Smith, B.O., Soares, D.C., Veltel, S.,
McIlhinney, R.A., White, J.H., and Barlow, P.N. (2004). J. Biol. Chem.
279, 48292–48306.
Brauner-Osborne, H., and Krogsgaard-Larsen, P. (1999). Br. J. Phar-
macol. 128, 1370–1374.
Couve, A., Calver, A.R., Fairfax, B., Moss, S.J., and Pangalos, M.N.
(2004). Biochem. Pharmacol. 68, 1527–1536.
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W.,
Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R.,
et al. (1998). Nature 396, 683–687.
Kerr, D.I., and Ong, J. (1995). Pharmacol. Ther. 67, 187–246.
Larkum, M.E., Zhu, J.J., and Sakmann, B. (1999). Nature 398, 338–
341.
Larkum, M.E., Zhu, J.J., and Sakmann, B. (2001). J. Physiol. 533,
447–466.
Mohler, H., and Fritschy, J.M. (1999). Trends Pharmacol. Sci. 20, 87–
89.Pe´rez-Garci, E., Gassmann, M., Bettler, B., and Larkum, M.E. (2006).
Neuron 50, this issue, 603–616.
Tamas, G., Lorincz, A., Simon, A., and Szabadics, J. (2003). Science
299, 1902–1905.
Vigot, R., Barbieri, S., Bra¨uner-Osborne, H., Turecek, R., Shigemoto,
R., Zhang, Y.-P., Luja´n, R., Jacobson, L.H., Biermann, B., Fritschy,
J.-M., et al. (2006). Neuron 50, this issue, 589–601.
DOI 10.1016/j.neuron.2006.05.005
